Atezolizumab-induced subacute cerebellar ataxia in a patient with extensive-stage small cell lung cancer

Recently, immune checkpoint inhibitors (ICIs) have become the standard treatment option for patients with lung cancer, including small cell lung cancer (SCLC). ICI-induced neurological immune-related adverse events are rare and exhibit diverse clinical manifestations, often leading to missed or dela...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Chia, Tseng, Kuan-Hua, Lai, Kuan-Lin, Chiang, Chi-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475224/
https://www.ncbi.nlm.nih.gov/pubmed/37667780
http://dx.doi.org/10.1177/17588359231192398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475224/
https://www.ncbi.nlm.nih.gov/pubmed/37667780
http://dx.doi.org/10.1177/17588359231192398

Ejemplares similares